Company record
Rising Pharma Holding, Inc.
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Rising Pharma Holding, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 29 | Class II | Rising Pharma Holding, Inc. Drug |
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-… Presence of Precipitate: medication was crystallizing and particles floating in the bottle |
| Mar 11 | Class II | Rising Pharma Holding, Inc. Drug |
Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51. Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing |